James N. Sleigh
@jamessleigh.bsky.social
500 followers
400 following
16 posts
MRC-funded group leader at UCL Queen Square Institute of Neurology studying peripheral nerve diseases to develop targeted gene therapies #CMT #ALS #SMA #AxonalTransport | he/him
Posts
Media
Videos
Starter Packs
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Ali Twelvetrees
@dozenoaks.bsky.social
· Aug 28
NeuroBioUK - Programme
9 AM Arrival, registration & coffee
Session 1: Organelle and synaptic signalling
Session Chair:
9:45 AM Introduction
9:50 AM Sally Horton, The Francis Crick Institute, "CDKL5 in synaptic formation,...
neurobiouk.sites.sheffield.ac.uk
James N. Sleigh
@jamessleigh.bsky.social
· Aug 13
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Reposted by James N. Sleigh
James N. Sleigh
@jamessleigh.bsky.social
· Jun 27
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Reposted by James N. Sleigh
James N. Sleigh
@jamessleigh.bsky.social
· May 30
Reposted by James N. Sleigh
Ewout Groen
@ewout.bsky.social
· Apr 21
Comprehensive analysis across SMN2 excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by defects
in the survival motor neuron 1 (SMN1) gene. Although disease severity partially correlates
with SMN2 copy number, ...
www.cell.com
Reposted by James N. Sleigh
Reposted by James N. Sleigh
Mike Fainzilber
@mfainzilber.bsky.social
· May 16